NCT00701805View on ClinicalTrials.gov

Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD)

PHASE2CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Secondary HyperparathyroidismHemodialysis
Interventions
DRUG

Paricalcitol

Intravenous (IV) paricalcitol, 3 times weekly, immediately before completion of hemodialysis.

Trial Locations (12)

Unknown

Aichi

Chiba

Fukuoka

Hokkaido

Ibaraki

Kanagawa

Kumamoto

Nagano

Nagasaki

Osaka

Saitama

Tokyo

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
collaborator

Abbott Japan Co.,Ltd

INDUSTRY

lead

Abbott

INDUSTRY